Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening

Toxicology

Volumn 278, Issue 3, 2010, Pages 250-255

  Greenhough, Sebastian ^a   Medine, Claire N ^a   Hay, David C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Hepatocyte; HESC; IPSC; Toxicity

Indexed keywords

CELL DIFFERENTIATION; CELL RENEWAL; CELL THERAPY; CELL VIABILITY; DNA POLYMORPHISM; EMBRYONIC STEM CELL; HUMAN; LIVER CELL; LIVER TOXICITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; TISSUE CULTURE;

CELL DIFFERENTIATION; CYTOTOXINS; HEPATOCYTES; HUMANS; LIVER; MODELS, BIOLOGICAL; PLURIPOTENT STEM CELLS; TOXICITY TESTS;

ANIMALIA;

EID: 78649743782     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.07.012     Document Type: Review

References (50)

1. Agarwal S., Holton K., Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008, 26(5):1117-1127.
2. Asgari S., Pournasr B., Salekdeh G.H., Ghodsizadeh A., Ott M., Baharvand H Induced pluripotent stem cells: a new era for hepatology. Hepatology 2010, [Epub] JHEPAT 3356 28 June 2010.
3. Baharvand H., Hashemi S.M., Kazemi Ashtiani S., Farrokhi A. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro. Int. J. Dev. Biol. 2006, 50(7):645-652.
4. Basma H., Soto-Gutiérrez A., Yannam G., Liu L., Ito R., Yamamoto T., Ellis E., Carson S., Sato S., Chen Y., Muirhead D., Navarro-Alvarez N., Wong R.J., Roy-Chowdhury J., Platt J.L., Mercer D.F., Miller J.D., Strom S.C., Kobayashi N., Fox I.J. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009, 136(3):990-999.
5. Brandon E., Raap C., Meijerman I., Beijnen J., Schellens J. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 2003, 189:233-246.
6. Cheng N., Wauthier E., Reid L. Mature human hepatocytes from ex vivo differentiation of alginate-encapsulated hepatoblasts. Tissue Eng. Part A 2008, 14(1):1-7.
7. Czyz J., Wiese C., Rolletschek A., Blyszczuk P., Cross M., Wobus A.M. Potential of embryonic and adult stem cells in vitro. Biol. Chem. 2003, 384:1391-1409.
8. Dalgetty D.M., Medine C.N., Iredale J.P., Hay D.C. Progress and future challenges in stem cell-derived liver technologies. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 297(August (2)):G241-G248.
9. Discher D.E., Janmey P., Wang Y. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310(5751):1139-1143.
10. Duan Y., Catana A., Meng Y., Yamamoto N., He S., Gupta S., Gambhir S., Zern Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells 2007, 25(12):3058-3068.
11. Fletcher J., Cui W., Samuel K., Black J., Hannoun Z., Currie I., Terrace J., Payne C., Filippi C., Newsome P., Forbes S.J., Ross J.A., Iredale J.P., Hay D.C. The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells 2008, 10(3):331-339.
12. Fox I., Strom S. To be or not to be: generation of hepatocytes from cells outside the liver. Gastroenterology 2008, 134(3):878-881.
13. Frühauf J., Mertsching H., Giri S., Frühauf N., Bader A. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver Int. 2009, 29(10):1553-1561.
14. Gadue P., Huber T.L., Paddison P.J., Keller G.M. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(November (45)):16806-16811.
15. Gebhardt R., Hengstler J., Müller D., Glöckner R., Buenning P., Laube B., Schmelzer E., Ullrich M., Utesch D., Hewitt N., Ringel M., Hilz B.R., Bader A., Langsch A., Koose T., Burger H.J., Maas J., Oesch F. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operation procedures. Drug Metab. Rev. 2003, 35:145-213.
16. Gómez-Lechón M.J., Lahoz A., Gombau L., Castell J.V., Donato MT In vitro evaluation of potential hepatotoxicity induced by drugs. Curr. Pharm. Des. 2010, March 18 [Epub ahead of print].
17. Guillouzo A. Liver cell models in in vitro toxicology. Environ. Health Perspect. 1998, 106(Suppl. April (2)):511-532.
18. Hannoun Z., Fletcher J., Greenhough S., Medine C.N., Samuel K., Sharma R., Pryde A., Black J.R., Ross J.A., Wilmut I., Iredale J.P., Hay D.C. The comparison between conditioned media and serum free media in human embryonic stem cell culture and differentiation. Cell. Reprog. 2010, 12(2):133-140.
19. Harm S., Stroble K., Hartmann J., Falkenhagen D Alginate-encapsulated human hepatoma C3A cells for use in a bioartificial liver device-the hybrid-MDS. Int. J. Artif. Organs 2009, 32(November (11)):769-778.
20. Hay D.C., Zhao D., Ross A., Mandalam R., Lebkowski J., Cui W. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 2007, 9(1):51-62.
21. Hay D.C., Fletcher J., Payne C., Terrace J., Gallagher R., Snoeys J., Black J., Wojtacha D., Samuel K., Hannoun Z., Pryde A., Filippi C., Currie I.S., Forbes S.J., Ross J.A., Newsome P.N., Iredale J.P. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(34):12301-12306.
22. Herrera M.B., Bruno S., Buttiglieri S., Tetta C., Gatti S., Deregibus M.C., Bussolati B., Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006, 24:2840-2850.
23. Imamura T., Cui L., Teng R., Johkura K., Okouchi Y., Asanuma K., Ogiwara N., Sasaki K. Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. Tissue Eng. 2004, 10(11-12):1716-1724.
24. Itskovitz-Eldor J., Schuldiner M., Karsenti D., Eden A., Yanuka O., Amit M., Soreq H., Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med. 2000, 6(February (2)):88-95.
25. Jalan R., Williams R. Bio-artificial liver support for acute liver failure: should we be using it to treat patients?. Transplantation 2002, 73:165-166.
26. Knoepfler P.S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009, 27(May (5)):1050-1056.
27. Lake B.G. Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica 2009, 39(August):582-596. No. 8.
28. Lazaro C.A., Rhim J.A., Yamada Y., Fausto N. Generation of hepatocytes from oval cell precursors in culture. Cancer Res. 1998, 58:5514-5522.
29. Lavon N., Yanuka O., Benvenisty N. Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation 2004, 72(5):230-238.
30. Lavon N., Benvenisty N.J. Study of hepatocyte differentiation using embryonic stem cells. Cell Biochem 2005, 96(December (6)):1193-1202.
31. Liu H., Ye Z., Kim Y., Sharkis S., Jang Y.Y. Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010, 51(May (5)):1810-1819.
32. Miranda J., Leite S., Muller-Vieira U., Rodrigues A., Carrondo M., Alves P. Towards an extended functional hepatocyte in vitro culture. Tissue Eng. Part C: Methods 2009, 15(2):157-167.
33. Orloff J., Douglas F., Pinheiro J., Levinson S., Branson M., Chaturvedi P., Ette E., Gallo P., Hirsch G., Mehta C., Patel N., Sabir S., Springs S., Stanski D., Evers M.R., Fleming E., Singh N., Tramontin T., Golub H. The future of drug development: advancing clinical trial design. Nat. Rev. Drug Discov. 2009, 8(December (12)):949-957.
34. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134(September (5)):877-886.
35. Rudzok S., Schlink U., Herbarth O., Bauer M. Measuring and modeling of binary mixture effects of pharmaceuticals and nickel on cell viability/cytotoxicity in the human hepatoma derived cell line HepG2. Toxicol. Appl. Pharmacol. 2010, 244(May (3)):336-343.
36. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 2000, 18:399-404.
37. Rippon H., Bishop A. Embryonic stem cells. Cell Prolif. 2004, 37(1):23-34.
38. Rogler L.E. Selective bipotential differentiation of mouse embryonic hepatoblasts in vitro. Am. J. Pathol. 1997, 150:591-602.
39. Si-Tayeb K., Noto F.K., Nagaoka M., Li J., Battle M.A., Duris C., North P.E., Dalton S., Duncan S.A. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010, 51(January (1)):297-305.
40. Sharma R., Greenhough S., Medine C.N., Hay D.C. Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J. Biomed. Biotechnol. 2010, 236147.
41. Sullivan G.J., Hay D.C., Park I.H., Fletcher J., Hannoun Z., Payne C.M., Dalgetty D., Black J.R., Ross J.A., Samuel K., Wang G., Daley G.Q., Lee J.H., Church G.M., Forbes S.J., Iredale J.P., Wilmut I. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010, 51(January (1)):329-335.
42. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(August (4)):663-676.
43. Takahashi K., Okita K., Nakagawa M., Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2007, 2(12):3081-3089.
44. Taylor J., Wilmut I., Sullivan G. What are the limits to cell plasticity?. Cell Res. 2010, 20(May (5)):502-503.
45. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
46. Touboul T., Hannan N.R., Corbineau S., Martinez A., Martinet C., Branchereau S., Mainot S., Strick-Marchand H., Pedersen R., Di Santo J., Weber A., Vallier L. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 2010, 51(May (5)):1754-1765.
47. van de Kerkhove M., Poyck P., Deurholt T., Hoekstra R., Chamuleau R., van Gulik T. Liver support therapy: an overview of the AMC-bioartificial liver research. Dig. Surg. 2005, 22(4):254-264.
48. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Südhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463(February (7284)):1035-1041.
49. Wong N., Lai P., Pang E., Leung T.W., Lau J.W., Johnson P.J. A comprehensive karyotypic study on human hepatocellular carcinoma by spectral karyotyping. Hepatology 2000, 32(November (5)):1060-1068.
50. Xie H.-G., Kim R.B., Wood A.J.J., Stein C.M. Molecular basis of ethnic differences in drug disposition and response. Annu. Rev. Pharmacol. Toxicol. 2001, 41:815-850.